Debt Obligations | Note 11 — Debt Obligations Credit Facilities and Repurchase Agreements Borrowings under our credit facilities and repurchase agreements are as follows ($ in thousands): December 31, 2018 December 31, 2017 Debt Collateral Debt Collateral Carrying Carrying Wtd. Avg. Carrying Carrying Wtd. Avg. UPB (1) Value (1) Value Note Rate UPB (1) Value (1) Value Note Rate Structured Business $375 million repurchase facility $ 336,428 $ 334,696 $ 467,680 4.75 % $ 103,818 $ 102,350 $ 145,850 3.90 % $100 million repurchase facility 71,017 70,837 98,597 4.31 % 2,835 2,445 6,600 3.61 % $75 million credit facility 10,237 10,237 16,889 4.31 % — — — — $75 million credit facility — — — — 9,000 8,999 16,000 3.61 % $50 million credit facility 14,160 14,159 17,700 4.57 % 32,560 32,538 40,700 3.61 % $50 million credit facility — — — — 3,700 3,581 4,625 4.88 % $35.9 million credit facility 30,855 30,512 44,100 4.87 % — — — — $25.5 million credit facility 18,552 18,552 34,000 5.07 % 14,065 13,920 18,753 4.12 % $25 million working capital facility — — — — 10,000 10,000 — 4.12 % $23.2 million credit facility 23,175 23,175 30,900 4.87 % — — — — $20 million credit facility 20,000 19,912 41,650 5.07 % — — — — $17.4 million credit facility 12,462 12,462 15,844 4.97 % — — — — $8 million credit facility 8,000 7,946 10,000 5.07 % — — — — $7.5 million credit facility — — — — 7,472 7,432 9,340 4.37 % Repurchase facilities - securities (2) 118,112 118,112 — 5.07 % 53,938 53,938 — 4.45 % $3 million master security agreement 1,168 1,168 — 3.19 % 1,834 1,834 — 3.21 % $2.2 million master security agreement 1,678 1,678 — 4.66 % — — — — Structured Business total $ 665,844 $ 663,446 $ 777,360 4.78 % $ 239,222 $ 237,037 $ 241,868 4.02 % Agency Business $750 million ASAP agreement $ 104,619 $ 104,619 $ 104,619 3.55 % $ 121,880 $ 121,880 $ 121,880 2.61 % $500 million repurchase facility 130,917 130,906 130,917 3.78 % 24,873 24,827 24,873 2.91 % $250 million credit facility 26,651 26,651 26,651 3.75 % 23,785 23,785 23,785 2.86 % $150 million credit facility 113,685 113,666 113,685 3.80 % 21,821 21,802 21,821 2.96 % $150 million credit facility 96,419 96,339 96,419 3.80 % 99,357 99,242 99,357 2.91 % Agency Business total $ 472,291 $ 472,181 $ 472,291 3.74 % $ 291,716 $ 291,536 $ 291,716 2.78 % Consolidated total $ 1,138,135 $ 1,135,627 $ 1,249,651 4.35 % $ 530,938 $ 528,573 $ 533,584 3.34 % (1) The debt carrying value for the Structured Business at December 31, 2018 and 2017 was net of unamortized deferred finance costs of $2.4 million and $2.2 million, respectively. The debt carrying value for the Agency Business at December 31, 2018 and 2017 was net of unamortized deferred finance costs of $0.1 million and $0.2 million, respectively. (2) At December 31, 2018 and 2017, these facilities were collateralized by CLO bonds retained by us with an aggregate principal balance of $114.2 million and $61.0 million, respectively, and B Piece bonds with an aggregate carrying value of $76.4 million and $27.8 million, respectively. Structured Business. We utilize credit facilities and repurchase agreements with various financial institutions to finance our Structured Business loans and investments as described below. At December 31, 2018 and 2017, the weighted average interest rate for the credit facilities and repurchase agreements of our Structured Business, including certain fees and costs, such as structuring, commitment, non-use and warehousing fees, was 5.07% and 4.51%, respectively. The leverage on our loan and investment portfolio financed through our credit facilities and repurchase agreements, excluding the securities repurchase facilities, working capital line of credit and the security agreements used to finance leasehold and capital expenditure improvements at our corporate office, was 70% and 72% at December 31, 2018 and 2017, respectively. We have a $300.0 million repurchase facility that bears interest at a rate of 175 basis points over LIBOR on multifamily senior mortgage loans, 350 basis points over LIBOR on junior mortgage loans and matures in March 2020, with a one-year extension option. The committed amount under the facility was temporarily increased $75.0 million to $375.0 million, which expires in March 2019. If the estimated market value of the loans financed in this facility decrease, we may be required to pay down borrowings under this facility. We have a $100.0 million repurchase facility to finance multifamily bridge loans that bears interest at a rate ranging from 175 basis points to 200 basis points over LIBOR (depending on the class of loan financed) and matures in June 2019, with a one-year extension option. The facility has a maximum advance rate of 80%. We have a $75.0 million credit facility to finance multifamily bridge loans that was scheduled to mature in February 2019 and bears interest at 175 basis points over LIBOR. In February 2019, we temporarily extended the maturity date to March 2019, with a one-month extension option, and are currently in negotiations to further amend the agreement. This facility includes a $25.0 million sublimit to finance healthcare related loans at an interest rate ranging from 212.5 basis points to 250 basis points over LIBOR depending on the type of healthcare facility financed and the advance rate. The facility has a maximum advance rate of 75% on multifamily bridge loans and 65% on healthcare related loans. We have another $75.0 million credit facility to finance bridge loans that bears interest at a rate of 200 basis points over LIBOR and matures in June 2019. The facility has a maximum advance rate of 70% to 75%, depending on the property type. We have a $50.0 million credit facility to finance multifamily loans that bears interest at a rate of 200 basis points over LIBOR and is scheduled to mature in February 2019. We are currently in negotiations to amend the agreement and extend its maturity. This facility has a maximum advance rate of 80%. We have another $50.0 million credit facility that bears interest at a rate ranging from 250 basis points to 325 basis points over LIBOR, depending on the type of healthcare facility financed, and matures in September 2019. The facility includes two one-year extension options and has a maximum advance rate of 80%. In the fourth quarter of 2018, we entered into a $35.9 million credit facility to finance a hotel property bridge loan. The facility bears interest at a rate of 230 basis points over LIBOR and matures in May 2020, with a six-month extension option. We have a $25.5 million credit facility used to finance a multifamily bridge loan. The facility bears interest at a rate of 250 basis points over LIBOR and matures in October 2019. We have a $25.0 million unsecured working capital line of credit that bears interest at a rate of 225 basis points over LIBOR. This line is scheduled to mature in June 2019 and is renewable annually. We have a $23.2 million credit facility used to finance a self storage bridge loan. The facility bears interest at a rate of 230 basis points over LIBOR and matures in February 2020, with a one-year extension option. We have a $20.0 million credit facility used to finance a healthcare facility bridge loan. The facility bears interest at a rate of 250 basis points over LIBOR and matures in March 2020, with a one-year extension option. We have a $17.4 million credit facility used to finance a multifamily bridge loan. The facility bears interest at a rate of 240 basis points over LIBOR and matures in June 2020, with a one-year extension option. We have an $8.0 million credit facility used to finance a healthcare facility bridge loan. The facility bears interest at a rate of 250 basis points over LIBOR and matures in August 2021. We had a $7.5 million credit facility used to finance a healthcare related bridge loan. The facility bore interest at a rate of 275 basis points over LIBOR and in September 2018 the loan collateralizing this facility paid off and we simultaneously repaid this facility. We have two uncommitted repurchase facilities that are used to finance securities we retained in connection with our CLOs and our purchases of B Piece bonds from SBL program securitizations. The facilities bear interest at rates ranging from 175 basis points to 315 basis points over LIBOR and have no stated maturity date. We have two notes payable under a master security agreement that was used to finance leasehold improvements to our corporate office, which were assumed as part of the Acquisition. The two notes bear interest at a weighted average fixed rate of 3.19%, require monthly amortization payments and mature in 2020. We have a master security agreement to finance certain capital expenditures. We have a $2.2 million note payable under this agreement which bears interest at a fixed rate of 4.60%, requires monthly amortization payments and matures in March 2021. Agency Business . We utilize credit facilities with various financial institutions to finance substantially all of our loans held-for-sale as described below. In the fourth quarter of 2018, we amended our Multifamily As Soon as Pooled ® Plus ("ASAP") agreement with Fannie Mae increasing the available credit to $750.0 million from $500.0 million. The ASAP agreement provides us with a warehousing credit facility for mortgage loans that are to be sold to Fannie Mae and serviced under the Fannie Mae DUS program. The ASAP agreement is not a committed line, has no expiration date and bears interest at a rate of 105 basis points over LIBOR, with a LIBOR Floor of 0.35%. In the fourth quarter of 2018, we amended our $200.0 million repurchase facility increasing the committed amount $300.0 million to $500.0 million. The facility also includes an accordion feature to increase the committed amount to $750.0 million, which is available through the maturity date. The facility bears interest at a rate of 127.5 basis points over LIBOR and matures in August 2019. The financial institution that provided this facility has a security interest in the underlying mortgage notes that serve as collateral for this facility. We have a $100.0 million repurchase facility that bears interest at a rate of 125 basis points over LIBOR and matures in June 2019. The committed amount under the facility was temporarily increased $150.0 million to $250.0 million, which expired in January 2019. The financial institution that provided this facility has a security interest in the underlying mortgage notes that serve as collateral for this facility. We have a $150.0 million credit facility that bears interest at a rate of 130 basis points over LIBOR that was scheduled to mature in January 2019. In January 2019, we amended this facility to extend the maturity date one year to January 2020 and reduce the interest rate 10 basis points to 120 basis points over LIBOR. The financial institution that provided this facility has a security interest in the underlying mortgage notes that serve as collateral for this facility. We have another $150.0 million credit facility that bears interest at a rate of 130 basis points over LIBOR and matures in July 2019. The financial institution that provided this facility has a security interest in the underlying mortgage notes that serve as collateral for this facility. We have a $50.0 million letter of credit facility with a financial institution to secure obligations under the Fannie Mae DUS program and the Freddie Mac SBL program. The facility bears interest at a fixed rate of 2.875%, matures in September 2020 and is primarily collateralized by our servicing revenue as approved by Fannie Mae and Freddie Mac. The facility includes a $5.0 million sublimit for an obligation under the Freddie Mac SBL program. At December 31, 2018, the letters of credit outstanding include $44.0 million for the Fannie Mae DUS program and $5.0 million for the Freddie Mac SBL program. CLOs We account for our CLO transactions on our consolidated balance sheet as financing facilities. Our CLOs are VIEs for which we are the primary beneficiary and are consolidated in our financial statements. The investment grade tranches are treated as secured financings, and are non-recourse to us. Borrowings and the corresponding collateral under our CLOs are as follows ($ in thousands): Collateral (3) Debt Loans Cash Carrying Wtd. Avg. Carrying Restricted Face Value Value (1) Rate (2) UPB Value Cash (4) December 31, 2018 CLO X $ 441,000 $ 436,384 4.01 % $ 539,007 $ 536,869 $ 20,993 CLO IX 356,400 352,244 3.92 % 440,906 439,691 20,094 CLO VIII 282,874 279,857 3.87 % 354,713 353,574 10,287 CLO VII 279,000 276,527 4.56 % 325,057 324,195 30,725 CLO VI 250,250 248,536 5.05 % 279,348 278,364 41,404 Total CLOs $ 1,609,524 $ 1,593,548 4.22 % $ 1,939,031 $ 1,932,693 $ 123,503 December 31, 2017 CLO IX $ 356,400 $ 351,042 2.97 % $ 372,350 $ 371,236 $ 88,650 CLO VIII 282,874 278,606 2.92 % 364,838 363,339 162 CLO VII 279,000 275,331 3.61 % 346,524 345,220 13,476 CLO VI 250,250 247,470 4.10 % 314,382 313,582 10,618 CLO V 267,750 265,973 4.06 % 347,797 346,803 2,203 Total CLOs $ 1,436,274 $ 1,418,422 3.48 % $ 1,745,891 $ 1,740,180 $ 115,109 (1) Debt carrying value is net of $16.0 million and $17.9 million of deferred financing fees at December 31, 2018 and 2017, respectively. (2) At December 31, 2018 and 2017, the aggregate weighted average note rate for our CLOs, including certain fees and costs, was 4.73% and 4.08%, respectively. (3) As of December 31, 2018 and 2017, there was no collateral at risk of default or deemed to be a “credit risk” as defined by the CLO indenture. (4) Represents restricted cash held for principal repayments as well as for reinvestment in the CLOs. Does not include restricted cash related to interest payments, delayed fundings and expenses. CLO X . In June 2018, we completed CLO X, issuing seven tranches of CLO notes through two newly-formed wholly-owned subsidiaries totaling $494.2 million. Of the total CLO notes issued, $441.0 million were investment grade notes issued to third party investors and $53.2 million were below investment grade notes retained by us. As of the CLO closing date, the notes were secured by a portfolio of loan obligations with a face value of $501.9 million, consisting primarily of bridge loans that were contributed from our existing loan portfolio. The financing has a stated maturity date in June 2028 and a four-year replacement period that allows the principal proceeds and sale proceeds (if any) of the loan obligations to be reinvested in qualifying replacement loan obligations, subject to the satisfaction of certain conditions set forth in the indenture. Thereafter, the outstanding debt balance will be reduced as loans are repaid. Initially, the proceeds of the issuance of the securities also included $58.1 million for the purpose of acquiring additional loan obligations for a period of up to 120 days from the CLO closing date, which were subsequently utilized, resulting in the issuer owning loan obligations with a face value of $560.0 million, representing leverage of 79%. We retained a residual interest in the portfolio with a notional amount of $119.0 million, including the $53.2 million below investment grade notes. The notes had an initial weighted average interest rate of 1.45% plus one-month LIBOR and interest payments on the notes are payable monthly. CLO IX. In December 2017, we completed CLO IX, issuing five tranches of CLO notes through two newly-formed wholly-owned subsidiaries totaling $388.2 million. Of the total CLO notes issued, $356.4 million were investment grade notes issued to third party investors and $31.8 million were below investment grade notes retained by us. As of the CLO closing date, the notes were secured by a portfolio of loan obligations with a face value of $387.3 million, consisting primarily of bridge loans that were contributed from our existing loan portfolio. The financing has a stated maturity date in December 2027 and a three-year replacement period that allows the principal proceeds and sale proceeds (if any) of the loan obligations to be reinvested in qualifying replacement loan obligations, subject to the satisfaction of certain conditions set forth in the indenture. Thereafter, the outstanding debt balance will be reduced as loans are repaid. Initially, the proceeds of the issuance of the securities also included $92.7 million for the purpose of acquiring additional loan obligations for a period of up to 120 days from the CLO closing date, which were subsequently utilized, resulting in the issuer owning loan obligations with a face value of $480.0 million, representing leverage of 74%. We retained a residual interest in the portfolio with a notional amount of $123.6 million, including the $31.8 million below investment grade notes. The notes had an initial weighted average interest rate of 1.36% plus LIBOR and interest payments on the notes are payable monthly. CLO VIII. In August 2017, we completed CLO VIII, issuing six tranches of CLO notes through two newly-formed wholly-owned subsidiaries totaling $312.1 million. Of the total CLO notes issued, $282.9 million were investment grade notes issued to third party investors and $29.2 million were below investment grade notes retained by us. As of the CLO closing date, the notes were secured by a portfolio of loan obligations with a face value of $293.7 million, consisting primarily of bridge loans that were contributed from our existing loan portfolio. The financing has a stated maturity date in August 2027 and a three-year replacement period that allows the principal proceeds and sale proceeds (if any) of the loan obligations to be reinvested in qualifying replacement loan obligations, subject to the satisfaction of certain conditions set forth in the indenture. Thereafter, the outstanding debt balance will be reduced as loans are repaid. Initially, the proceeds of the issuance of the securities also included $71.3 million for the purpose of acquiring additional loan obligations for a period of up to 120 days from the CLO closing date, which were subsequently utilized, resulting in the issuer owning loan obligations with a face value of $365.0 million, representing leverage of 78%. We retained a residual interest in the portfolio with a notional amount of $82.1 million, including the $29.2 million below investment grade notes. The notes had an initial weighted average interest rate of 1.31% plus LIBOR and interest payments on the notes are payable monthly. CLO VII. In April 2017, we completed CLO VII, issuing to third party investors three tranches of investment grade CLOs through two newly-formed wholly-owned subsidiaries totaling $279.0 million. As of the CLO closing date, the notes were secured by a portfolio of loan obligations with a face value of $296.2 million, consisting primarily of bridge loans that were contributed from our existing loan portfolio. The financing has a stated maturity date in April 2027 and a three-year replacement period that allows the principal proceeds and sale proceeds (if any) of the loan obligations to be reinvested in qualifying replacement loan obligations, subject to the satisfaction of certain conditions set forth in the indenture. Thereafter, the outstanding debt balance will be reduced as loans are repaid. Initially, the proceeds of the issuance of the securities also included $63.8 million for the purpose of acquiring additional loan obligations for a period of up to 120 days from the CLO closing date, which were subsequently utilized, resulting in the issuer owning loan obligations with a face value of $360.0 million, representing leverage of 78%. We retained a residual interest in the portfolio with a notional amount of $81.0 million. The notes had an initial weighted average interest rate of 1.99% plus LIBOR and interest payments on the notes are payable monthly. CLO VI. In August 2016, we completed CLO VI, issuing to third party investors three tranches of investment grade CLOs through two newly-formed wholly-owned subsidiaries totaling $250.3 million. As of the CLO closing date, the notes were secured by a portfolio of loan obligations with a face value of $275.4 million, consisting primarily of bridge loans that were contributed from our existing loan portfolio. The financing has a stated maturity date in September 2026 and a three year replacement period that allows the principal proceeds and sale proceeds (if any) of the loan obligations to be reinvested in qualifying replacement loan obligations, subject to the satisfaction of certain conditions set forth in the indenture. Thereafter, the outstanding debt balance will be reduced as loans are repaid. Initially, the proceeds of the issuance of the securities also included $49.6 million for the purpose of acquiring additional loan obligations for a period of up to 120 days from the closing date of the CLO, which were subsequently utilized, resulting in the issuer owning loan obligations with a face value of $325.0 million , representing leverage of 77%. We retained a residual interest in the portfolio with a notional amount of $74.8 million. The notes had an initial weighted average interest rate of 2.48% plus LIBOR and interest payments on the notes are payable monthly. CLO V. In June 2018, we unwound CLO V, redeeming $267.8 million of outstanding notes which were repaid primarily from the refinancing of the remaining assets within our existing financing facilities (including CLO X), as well as with cash held by CLO V, and expensed $1.3 million of deferred financing fees into interest expense on the consolidated statements of income. CLO IV. In September 2017, we unwound CLO IV, redeeming $219.0 million of our outstanding notes which were repaid primarily from the refinancing of the remaining assets within our existing financing facilities (including CLO VIII), as well as with cash held by CLO IV, and expensed $1.1 million of deferred financing fees into interest expense on the consolidated statements of income. CLO III . In December 2016, we unwound CLO III, redeeming $281.3 million of our outstanding notes which were repaid primarily from the refinancing of the remaining assets within our financing facilities, as well as with cash held by the CLO, and expensed $1.0 million of deferred fees into interest expense in the consolidated statements of income. Luxembourg Debt Fund In November 2017, we formed a $100.0 million Debt Fund and issued $70.0 million of floating rate notes to third party investors which bore an initial interest rate of 4.15% over LIBOR. The notes mature in 2025 and we retained a $30.0 million equity interest in the Debt Fund. The Debt Fund is a VIE for which we are the primary beneficiary and is consolidated in our financial statements. The Debt Fund is secured by a portfolio of loan obligations and cash with a face value of $100.0 million, which includes first mortgage bridge loans, senior participation interests in first mortgage bridge loans, subordinate participation interest in first mortgage bridge loans and participation interests in mezzanine loans. The Debt Fund allows, for a period of three years, principal proceeds from portfolio assets to be reinvested in qualifying replacement assets, subject to certain conditions. Borrowings and the corresponding collateral under our Debt Fund are as follows ($ in thousands): Collateral (3) Debt Loans Cash Face Carrying Wtd. Avg. Carrying Restricted Period Value Value (1) Rate (2) UPB Value Cash (4) December 31, 2018 $ 70,000 $ 68,183 6.75 % $ 69,186 $ 68,924 $ 30,814 December 31, 2017 $ 70,000 $ 68,084 % $ 96,995 $ 96,564 $ 3,005 (1) Debt carrying value is net of $1.8 million and $1.9 million of deferred financing fees at December 31, 2018 and 2017, respectively. (2) At December 31, 2018 and 2017, the aggregate weighted average note rate, including certain fees and costs, was 7.49% and 6.05%, respectively. (3) At both December 31, 2018 and 2017, there was no collateral at risk of default or deemed to be a “credit risk.” (4) Represents restricted cash held for reinvestment. Excludes restricted cash related to interest payments, delayed fundings and expenses. Senior Unsecured Notes In March 2018, we issued $100.0 million aggregate principal amount of 5.625% senior unsecured notes due in May 2023 (the “Initial Notes”) in a private placement, and, in May 2018, we issued an additional $25.0 million (the “Reopened Notes” and, together with the Initial Notes, the “5.625% Notes,”) which brought the aggregate outstanding principal amount to $125.0 million. The Reopened Notes are fully fungible with, and rank equally in right of payment with the Initial Notes. We received total proceeds of $122.3 million from the issuances, after deducting the underwriting discount and other offering expenses. We used the net proceeds from the Initial Notes to fully redeem our 7.375% Notes totaling $97.9 million and the net proceeds from the Reopened Notes to make investments and for general corporate purposes. The 5.625% Notes are unsecured and can be redeemed by us at any time prior to April 1, 2023, at a redemption price equal to 100% of the aggregate principal amount, plus a “make-whole” premium and accrued and unpaid interest. We have the right to redeem the 5.625% Notes on or after April 1, 2023, at a redemption price equal to 100% of the aggregate principal amount, plus accrued and unpaid interest. The interest is paid semiannually in May and November starting in November 2018. At December 31, 2018, the debt carrying value of the 5.625% Notes was $122.5 million, net of $2.5 million of deferred financing fees, and the weighted average note rate was 6.08%, including certain fees and costs. At December 31, 2017, the debt carrying value of our 7.375% Notes was $95.3 million, which was net of $2.6 million of deferred financing fees, and the weighted average note rate was 8.16%. Convertible Senior Unsecured Notes In July 2018, we issued $264.5 million in aggregate principal amount of 5.25% Convertible Notes through two separate private placement offerings, which includes the exercised purchaser’s total over-allotment option of $34.5 million. The 5.25% Convertible Notes pay interest semiannually in arrears and are scheduled to mature in July 2021, unless earlier converted or repurchased by the holders pursuant to their terms. The initial conversion rates of the two offerings ($115.0 million issued on July 3, 2018 and $149.5 million issued on July 20, 2018) were 86.9943 shares and 77.8331 shares of common stock per $1,000 of principal, respectively, representing a conversion price of $11.50 per share and $12.85 per share of common stock, respectively. At December 31, 2018, the conversion rates of the two offerings ($115.0 million issued on July 3, 2018 and $149.5 million issued on July 20, 2018) were 88.3681 shares and 79.0623 shares of common stock per $1,000 of principal, respectively, representing a conversion price of $11.32 per share and $12.65 per share of common stock, respectively. We received proceeds totaling $256.1 million from the offerings of our 5.25% Convertible Notes, net of the underwriter’s discount and fees, which is being amortized through interest expense over the life of such notes. We used the net proceeds from the issuance primarily for the initial exchange of $127.6 million of our 5.375% Convertible Notes and $99.8 million of our 6.50% Convertible Notes for a combination of $219.8 million in cash (which includes accrued interest) and 6,820,196 shares of our common stock. The remaining net proceeds were used for general corporate purposes. During 2018, we recorded a loss on extinguishment of debt of $5.0 million in connection with these exchanges, which included an inducement charge of $1.1 million. At December 31, 2018, there were $5.5 million and $0.1 million aggregate principal amount remaining of our 5.375% Convertible Notes and 6.50% Convertible Notes, respectively. The initial conversion rates of the 5.375% Convertible Notes and 6.50% Convertible Notes were 107.7122 shares and 119.3033 shares, respectively, of common stock per $1,000 of principal, which represented a conversion price of $9.28 per share and $8.38 per share of common stock, respectively. At December 31, 2018, the 5.375% Convertible Notes and 6.50% Convertible Notes had conversion rates of 111.4750 shares and 126.1380 shares, respectively, of common stock per $1,000 of principal, which represented a conversion price of $8.97 per share and $7.93 per share of common stock, respectively. The 5.375% Convertible Notes and 6.50% Convertible Notes pay interest semiannually in arrears and have scheduled maturity dates in November 2020 and October 2019, respectively, unless earlier converted or repurchased by the holders pursuant to their terms. Our convertible senior unsecured notes are not redeemable by us prior to their maturities and are convertible into, at our election, cash, shares of our common stock or a combination of both, subject to the satisfaction of certain conditions and during specified periods. The conversion rates are subject to adjustment upon the occurrence of certain specified events and the holders may require us to repurchase all, or any portion, of their notes for cash equal to 100% of the principal amount, plus accrued and unpaid interest, if we undergo a fundamental change specified in the agreements. We intend to settle the principal balance of our convertible debt in cash and have not assumed share settlement of the principal balance for purposes of computing EPS. At the time of issuance, there is no precedent or policy that would indicate that we would settle the principal in shares or the conversion spread in cash. Accounting guidance requires that convertible debt instruments with cash settlement features, including partial cash settlement, account for the liability component and equity component (conversion feature) of the instrument separately. The initial value of the liability component reflects the present value of the discounted cash flows using the nonconvertible debt borrowing rate at the time of the issuance. The debt discount represents the difference between the proceeds received from the issuance and the initial carrying value of the liability component, which is accreted back to the notes principal amount through interest expense over the term of the notes, which was 2.49 years and 2.41 years at December 31, 2018 and 2017, respectively, on a weighted average basis. The UPB, unamortized discount and net carrying amount of the liability and equity components of our convertible notes were as follows (in thousands): Liability Equity Component Component Unamortized Unamortized Deferred Net Carrying Net Carrying Period UPB Debt Discount Financing Fees Value Value December 31, 2018 $ 270,057 $ 8,229 $ 7,060 $ 254,768 $ 9,436 December 31, 2017 $ 243,750 $ 5,742 $ 6,721 $ 231,287 $ 6,733 During 2018, we incurred total aggregate interest expense on the notes of $21.1 million, of which $13.4 million, $4.8 million and $2.9 million related to the cash coupon, amortization of the deferred financing fees and of the debt discount, respectively. During 2017, we incurred total aggregate interest expense on the notes of $10.1 million, of which $7.4 million, $1.6 million and $1.1 million related to the cash coupons, amortization of the deferred financing fees and of the debt discount, respectively. Including the amortization of the deferred financing fees and debt discount, our weighted average total cost of the notes was 7.45% and 7.96% at December 31, 2018 and 2017, respectively. Junior Subordinated Notes In 2017, we purchased, at a discount, $20.9 million of our junior subordinated notes with a carrying value of $19.8 million and recorded a gain on extinguishment of debt of $7.1 million. As a result, we settled our related equity investment and extinguished $21.5 million of notes. The carrying value of borrowings under our junior subordinated notes were $140.3 million and $139.6 million at December 31, 2018 and 2017, respectively, which is net of a deferred amount of $12.0 million and $12.5 million, respectively, (which is amortized into interest expense over the life of the notes) and deferred financing fees of $2.1 million and $2.2 million, respectively. These notes have maturities ranging from March 2034 through April 2037 and pay interest quarterly at a floating rate based on LIBOR. The current weighted average note rate was 5.66% and 4.53% at December 31, 2018 and 2017, respectively. Including certain fees and costs, the weighted average note rate was 5.75% and 4.63% at December 31, 2018 and 2017, respectively. Related Party Financing In connection with the Acquisition, |